Biogaia Ab Stock Current Valuation
| BIOG-B Stock | SEK 105.80 1.10 1.05% |
Valuation analysis of BioGaia AB helps investors to measure BioGaia AB's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that BioGaia AB's price fluctuation is very steady at this time. Calculation of the real value of BioGaia AB is based on 3 months time horizon. Increasing BioGaia AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BioGaia AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioGaia Stock. However, BioGaia AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 105.8 | Real 89.99 | Hype 105.8 | Naive 100.89 |
The real value of BioGaia Stock, also known as its intrinsic value, is the underlying worth of BioGaia AB Company, which is reflected in its stock price. It is based on BioGaia AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioGaia AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioGaia AB helps investors to forecast how BioGaia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioGaia AB more accurately as focusing exclusively on BioGaia AB's fundamentals will not take into account other important factors: BioGaia AB Company Current Valuation Analysis
BioGaia AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BioGaia AB Current Valuation | 7.35 B |
Most of BioGaia AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioGaia AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BioGaia AB has a Current Valuation of 7.35 B. This is 48.81% lower than that of the Healthcare sector and about the same as Drug Manufacturers - Specialty & Generic (which currently averages 7.43 B) industry. The current valuation for all Sweden stocks is 55.77% higher than that of the company.
BioGaia Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioGaia AB's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioGaia AB could also be used in its relative valuation, which is a method of valuing BioGaia AB by comparing valuation metrics of similar companies.BioGaia AB is currently under evaluation in current valuation category among its peers.
BioGaia Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.34 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 7.35 B | |||
| Shares Outstanding | 97.28 M | |||
| Shares Owned By Insiders | 3.59 % | |||
| Shares Owned By Institutions | 50.15 % | |||
| Price To Earning | 33.68 X | |||
| Price To Book | 4.77 X | |||
| Price To Sales | 8.01 X | |||
| Revenue | 1.1 B | |||
| Gross Profit | 801.93 M | |||
| EBITDA | 476.89 M | |||
| Net Income | 373.58 M | |||
| Cash And Equivalents | 1.48 B | |||
| Cash Per Share | 18.18 X | |||
| Total Debt | 10.4 M | |||
| Debt To Equity | 4.20 % | |||
| Current Ratio | 3.70 X | |||
| Book Value Per Share | 19.53 X | |||
| Cash Flow From Operations | 318.94 M | |||
| Earnings Per Share | 2.70 X | |||
| Price To Earnings To Growth | 1.90 X | |||
| Target Price | 136.5 | |||
| Number Of Employees | 212 | |||
| Beta | 0.63 | |||
| Market Capitalization | 10.57 B | |||
| Total Asset | 2.21 B | |||
| Working Capital | 289 M | |||
| Current Asset | 360 M | |||
| Current Liabilities | 71 M | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.48 % | |||
| Net Asset | 2.21 B |
About BioGaia AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioGaia AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioGaia AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioGaia AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BioGaia Stock
BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.